4//SEC Filing
Dexter Susan 4
Accession 0001493152-23-005468
CIK 0001106838other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 4:48 PM ET
Size
7.3 KB
Accession
0001493152-23-005468
Insider Transaction Report
Form 4
Dexter Susan
Chief Technical Officer
Transactions
- Disposition to Issuer
Common Stock
2023-01-07−14,627→ 9,040 total - Award
Common Stock
2023-01-07+14,627→ 23,667 total
Footnotes (3)
- [F1]On December 14, 2022, the Reporting Person was granted 14,627 restricted stock units to be settled in shares of common stock, par value $0.0001. On January 7, 2023, the 14,627 restricted stock units granted to the Reporting Person were rescinded and canceled. On the same day, the Reporting Person was granted a restricted stock award of 14,627 shares of common stock. The shares in connection with the restricted stock award become fully vested on January 1, 2024, provided the Reporting Person remains in continuous service through such date.
- [F2]A Form 4 that was filed by the Reporting Person on December 22, 2022, incorrectly included amounts in Column 5 of Table I that did not reflect a 14:1 reverse stock split of the Issuer's common stock, effective September 16, 2022.
- [F3]Includes unvested restricted stock units.
Documents
Issuer
Sonnet BioTherapeutics Holdings, Inc.
CIK 0001106838
Entity typeother
Related Parties
1- filerCIK 0001806764
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 4:48 PM ET
- Size
- 7.3 KB